BDBM224232 3-{6-(5- chloropyridin-3-yl)- 7-[(trans-4- methylcyclohexyl) methyl]-8-[(trans)-3- methylhexahydrocyclo- penta[b][1,4]oxazin- 4(4ah)-yl]-7h-purin- 2-yl}-1,2,4- oxadiazol-5(4h)-one (racemic; major diastereomer)::US9540377, 16.151

SMILES CC1CO[C@@H]2CCC[C@H]2N1c1nc2nc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1

InChI Key InChIKey=ORXYRXMKBNCXOQ-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 224232   

TargetE3 ubiquitin-protein ligase Mdm2 [17-125](Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 224232BDBM224232(US9540377, 16.151 | 3-{6-(5- chloropyridin-3-yl)- ...)
Affinity DataIC50: 1.70nMT: 2°CAssay Description:An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2018
Entry Details
US Patent